Marcio Souza, Director at Aeglea BioTherapeutics, Inc. (AGLE), bought 180,000 shares at $0.56 ($101K) on 2022-08-25, disclosed to the SEC on 2022-08-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.56 | 90,000 | $50K | 50.0% |
| 2 | $0.56 | 90,000 | $50K | 50.0% |
| Total | $0.56 avg | 180,000 | $101K | 100% |
| Filing → |
| PRAX | BUY | 2022-06-09 | $50K | — | Filing → |
| PRAX | BUY | 2021-08-19 | $301K | — | Filing → |
| PRAX | BUY | 2020-11-10 | $201K | — | Filing → |